Aethlon Medical, Inc. (AEMD)
NASDAQ: AEMD · Real-Time Price · USD
2.210
-0.730 (-24.83%)
At close: May 29, 2026, 4:00 PM EDT
2.196
-0.014 (-0.63%)
After-hours: May 29, 2026, 7:56 PM EDT
Aethlon Medical Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
9
Market Cap
3.47M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | - | - | - |
| Mar 31, 2024 | - | - | - |
| Mar 31, 2023 | 574.25K | 280.08K | 95.21% |
| Mar 31, 2022 | 294.17K | -364.94K | -55.37% |
| Mar 31, 2021 | 659.10K | 8.92K | 1.37% |
| Mar 31, 2020 | 650.19K | 420.56K | 183.15% |
| Mar 31, 2019 | 229.63K | 80.00K | 53.47% |
| Mar 31, 2018 | 149.63K | -242.45K | -61.84% |
| Mar 31, 2017 | 392.07K | -494.50K | -55.78% |
| Mar 31, 2016 | 886.57K | 124.16K | 16.28% |
| Mar 31, 2015 | 762.42K | -861.35K | -53.05% |
| Mar 31, 2014 | 1.62M | 393.77K | 32.01% |
| Mar 31, 2013 | 1.23M | -129.62K | -9.53% |
| Mar 31, 2012 | 1.36M | - | - |
| Mar 31, 2011 | - | - | - |
| Mar 31, 2010 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| INVO Fertility | 6.94M |
| Beyond Air | 6.92M |
| Tenon Medical | 4.60M |
| Biomerica | 4.33M |
| Intelligent Bio Solutions | 3.91M |
| ENvue Medical | 2.18M |
| Catheter Precision | 1.11M |
| iTonic Holdings | 523.03K |
AEMD News
- 10 days ago - Aethlon Medical Monitoring Current Ebola Outbreak and Reaffirms Outbreak/Pandemic Preparedness - PRNewsWire
- 2 months ago - Aethlon Medical Transcript: Emerging Growth Conference 91 - Transcripts
- 2 months ago - Aethlon Medical Slides: Corporate presentation - Filings
- 2 months ago - Advancements in Novel Immunotherapeutics in The Oncology Battle - Newsfile Corp
- 2 months ago - Aethlon Medical advances to final cohort in AEMD-2022-06 trial - TheFly
- 2 months ago - Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review - PRNewsWire
- 2 months ago - Aethlon Medical Transcript: Life Sciences Virtual Investor Forum - Transcripts
- 2 months ago - Aethlon Medical to evaluate range of strategic opportunities - TheFly